Tobacco Addiction: Implications for Treatment and Cancer Prevention

The American Society of Clinical Oncology and the National Cancer Institute convened a symposium in June 1996 on tobacco addiction. Additional support for the symposium was provided by the American Medical Women's Association and the American Society of Preventive Oncology. The goals of this co...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 1997-12, Vol.89 (24), p.1852-1867
Main Authors: Cinciripini, Paul M., Hecht, Stephen S., Henningfield, Jack E., Manley, Marc W., Kramer, Barnett S.
Format: Article
Language:English
Subjects:
Addictions
Biological and medical sciences
Conferences
Depression - complications
Epidemiology
Health Policy
Humans
Lung cancer
Medical sciences
National Institutes of Health (U.S.)
Neoplasms - epidemiology
Neoplasms - etiology
Neoplasms - prevention & control
Risk Factors
Smoking Cessation
Societies, Medical
Tobacco
Tobacco Use Disorder - complications
Tobacco Use Disorder - epidemiology
Tobacco Use Disorder - psychology
Tobacco Use Disorder - therapy
Tumors
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The American Society of Clinical Oncology and the National Cancer Institute convened a symposium in June 1996 on tobacco addiction. Additional support for the symposium was provided by the American Medical Women's Association and the American Society of Preventive Oncology. The goals of this conference were to describe the burden and public health consequences of tobacco addiction, to describe the state of science for the treatment of nicotine dependence, and to explore new strategies to increase quit rates and to prevent the uptake of tobacco use. This article summarizes and integrates the meeting presentations on tobacco addiction and includes the topics of smoking prevalence; psychobiologic aspects of nicotine dependence; and implications for disease, treatment, and prevention. Comments on regulatory approaches and national strategies for reducing dependence are also summarized in presentations by Dr. David Kessler, former Food and Drug Administration Commissioner, and Dr. C. Everett Koop, former U.S. Surgeon General. “Tobacco drieth the brain, dimmeth the sight, vitiateth the smell, hurteth the stomach, destroyeth the concoction, disturbeth the humors and spirits, corrupteth the breath, induceth a trembling of the limbs, exsicateth the windpipe, lungs, and liver, annoyeth the milt, scortcheth the heart, and causeth the blood to be adjusted.” Tobias Verner, 1577-1660
ISSN:0027-8874
1460-2105
DOI:10.1093/jnci/89.24.1852